Analysis: ANG Lifesciences India Limited

BSE:ANG Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹44 cr
RS rating: 81 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for ANG Lifesciences India Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.